Protokinetix Financials
| PKTX Stock | USD 0.01 0.0001 0.81% |
Protokinetix |
Please note, the imprecision that can be found in Protokinetix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Protokinetix. Check Protokinetix's Beneish M Score to see the likelihood of Protokinetix's management manipulating its earnings.
Protokinetix Stock Summary
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins or anti-aging glycoproteins . ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio. Protokinetix is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US7437221002 |
| Business Address | 412 Mulberry Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.protokinetix.com |
| Phone | 740 434 5041 |
| Currency | USD - US Dollar |
Protokinetix Key Financial Ratios
Protokinetix's financial ratios allow both analysts and investors to convert raw data from Protokinetix's financial statements into concise, actionable information that can be used to evaluate the performance of Protokinetix over time and compare it to other companies across industries.| Return On Equity | -4.03 | |||
| Return On Asset | -2.22 | |||
| Beta | 0.13 |
Protokinetix Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Protokinetix's current stock value. Our valuation model uses many indicators to compare Protokinetix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Protokinetix competition to find correlations between indicators driving Protokinetix's intrinsic value. More Info.Protokinetix is considered to be number one stock in return on equity category among its peers. It is regarded second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Protokinetix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Protokinetix's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Protokinetix Systematic Risk
Protokinetix's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Protokinetix volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Protokinetix correlated with the market. If Beta is less than 0 Protokinetix generally moves in the opposite direction as compared to the market. If Protokinetix Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Protokinetix is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Protokinetix is generally in the same direction as the market. If Beta > 1 Protokinetix moves generally in the same direction as, but more than the movement of the benchmark.
Protokinetix March 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Protokinetix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Protokinetix. We use our internally-developed statistical techniques to arrive at the intrinsic value of Protokinetix based on widely used predictive technical indicators. In general, we focus on analyzing Protokinetix Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Protokinetix's daily price indicators and compare them against related drivers.
| Downside Deviation | 9.85 | |||
| Information Ratio | 0.0924 | |||
| Maximum Drawdown | 55.33 | |||
| Value At Risk | (12.84) | |||
| Potential Upside | 24.0 |
Additional Tools for Protokinetix Pink Sheet Analysis
When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.